CFTR and cystic fibrosis: Even if most of the CF carriers are asymptomatic, it appears plausible that selected heterozygous carriers undergo a reduction in the normal CFTR protein function as a response to environmental factors or epigenetic regulation, developing clinical manifestations [41].